·1 хв читання · 61 слово·👁 5.9K↗ 3
Pfizer begins Covid pill study in high-risk children aged 6-17
The drugmaker plans to enroll 140 non-hospitalised children who are at high risk of developing severe illness in the study, across 2 groups of 6- to 17-year-olds.
One group will include those at least 40 kgs in weight and the other will consist of those between 20 kgs and 40 kgs.